Current Approach to Renal Transplantation Candidates and Potential Donors with Viral Hepatitis
By:
References
- Organization WH. Global hepatitis report 2017. World Health Organization, 2017.
- Seyahi N, Ateş K and Süleymanlar G. Current Status of Renal Replacement Therapy in Turkey: A Summary of the Turkish Society of Nephrology Registry Report. Current Status of Renal Replacement Therapy in Turkey 2020.
- Lim JK, Nguyen MH, Kim WR, et al. Prevalence of chronic hepatitis B virus infection in the United States. Official journal of the American College of Gastroenterology| ACG 2020; 115: 1429-1438.
- Liaw Y-F and Chu C-M. Hepatitis B virus infection. The lancet 2009; 373: 582-592.
- Liver EAFTSOT. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of hepatology 2017; 67: 370-398.
- Terrault NA, Lok AS, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67: 1560-1599.
- Nguyen MH, Wong G, Gane E, et al. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clinical microbiology reviews 2020; 33: e00046-00019.
- Fanning GC, Zoulim F, Hou J, et al. Therapeutic strategies for hepatitis B virus infection: towards a cure. Nature reviews Drug discovery 2019; 18: 827-844.
- Duhart Jr B, Honaker MR, Shokouh‐Amiri M, et al. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transplant infectious disease 2003; 5: 126-131.
- Kanaan N, Kabamba B, Maréchal C, et al. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. Journal of clinical virology 2012; 55: 233-238.
- Soi V and Soman S. Preventing hepatitis B in the dialysis unit. Advances in chronic kidney disease 2019; 26: 179-184.
- Udomkarnjananun S, Takkavatakarn K, Praditpornsilpa K, et al. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis. Journal of nephrology 2020; 33: 343-354.
- Khemichian S, Kahn J and Terrault NA. Use of Hepatitis B Virus–Positive Organs in Organ Transplantation. Clinics in Liver Disease 2021; 25: 841-857.
- Fernández-Galindo DA, de la Luz Galván-Ramírez M, Andrade-Sierra J, et al. Occult hepatitis B in kidney transplants recipients and donors from Western Mexico. International Journal of Infectious Diseases 2020; 91: 17-21.
- Huprikar S, Danziger‐Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus–positive donors: consensus guidelines for recipient management. American Journal of Transplantation 2015; 15: 1162-1172.
- Yap DY, Tang CS, Yung S, et al. Long-term outcome of renal transplant recipients with chronic hepatitis B infection—impact of antiviral treatments. Transplantation 2010; 90: 325-330.
- Yap DY, Yung S, Tang CS, et al. Entecavir treatment in kidney transplant recipients infected with hepatitis B. Clinical Transplantation 2014; 28: 1010-1015.
- Ridruejo E. Antiviral treatment for chronic hepatitis B in renal transplant patients. World Journal of Hepatology 2015; 7: 189.
- Ng C, Danguilan R, Pamugas G, et al. Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010. In: Transplantation Proceedings 2018, pp.3242-3248. Elsevier.
- Wang X-d, Liu J-p, Song T-r, et al. Kidney Transplantation From Hepatitis B Surface Antigen (HB-sAg)–Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China. Clinical Infectious Diseases 2021; 72: 1016-1023.
- Nho KW, Kim YH, Han DJ, et al. Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis: a single-center experience. Transplantation 2015; 99: 133-138.
- 22. Simmonds P. The origin of hepatitis C virus. Hepatitis C virus: from molecular virology to anti-viral therapy 2013: 1-15.
- Lingala S and Ghany MG. Natural history of hepatitis C. Gastroenterology Clinics 2015; 44: 717-734.
- Scott DR, Wong JK, Spicer TS, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation 2010; 90: 1165-1171.
- Disease K and Work IGOKHC. KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney international supplements 2018; 8: 91.
- Eason JD, Gonwa TA, Davis C, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). American Journal of Transplantation 2008; 8: 2243-2251.
- Paramesh AS, Davis JY, Mallikarjun C, et al. Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis. Transplantation 2012; 94: 250-254.
- Cruzado JM, Carrera M, Torras J, et al. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. American Journal of Transplantation 2001; 1: 171-178.
- Hammoud H, Haem J, Laurent B, et al. Glomerular disease during HCV infection in renal transplantation. Nephrology Dialysis Transplantation 1996; 11: 54-55.
- Sawinski D, Kaur N, Ajeti A, et al. Successful treatment of hepatitis C in renal transplant recipients with direct‐acting antiviral agents. American Journal of Transplantation 2016; 16: 1588-1595.
- Kamar N, Marion O, Rostaing L, et al. Efficacy and safety of sofosbuvir‐based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. American Journal of Transplantation 2016; 16: 1474-1479.
Language: English
Page range: 135 - 144
Published on: Mar 29, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2023 Berfu Korucu, Sena Ulu, Ozkan Gungor, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.